SCA has an average 12-month price target of $40.57 per share, according to the report. The ASC company’s stock has a one-year high of $40.99 and a one-year low of $26.55.
More articles on transactions and valuation issues:
8 new ASCs in August 2015
Q2 industry update: How did ASC companies fare?
Surgery Partners files for IPO: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
